Literature DB >> 19789612

Intravitreal bevacizumab injection in a 14-year-old Vogt-Koyanagi-Harada patient with choroidal neovascular membrane.

Lina Raffa, Ahmed Bawazeer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789612     DOI: 10.3129/i09-144

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  3 in total

1.  Rebound inflammation after an intravitreal injection in Vogt-Koyanagi-Harada syndrome.

Authors:  Richa Ranjan; Manisha Agarwal
Journal:  Indian J Ophthalmol       Date:  2018-06       Impact factor: 1.848

2.  Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization.

Authors:  Ahmad M Mansour; Friederike Mackensen; Padmamalini Mahendradas; Moncef Khairallah; Timothy Yy Lai; Ziad Bashshur
Journal:  Clin Ophthalmol       Date:  2012-08-01

3.  Management of recurrent inflammatory choroidal neovascular membrane secondary to Vogt-Koyanagi-Harada syndrome, using combined intravitreal injection of bevacizumab and triamcinolone acetate.

Authors:  Sivakami A Pai; Sudhira P Hebri; Afra M Lootah
Journal:  Indian J Ophthalmol       Date:  2012 Nov-Dec       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.